Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), will present at the 43rd Annual J.P. Morgan Healthcare ...

Graft-Versus-Host disease market Insights. DelveInsight's Graft-Versus-Host Disease Market report offers an in-depth understanding of the epidemiology and ...

This detailed review of HSBC Midcap Fund evaluates its recent performance, comparing it to the Nifty index, and analyzes key ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

Germany's biologics market, the largest in Europe, is expected to grow at a 3.8% CAGR from 2025 to 2035. AI is driving this growth by enhancing R&D, optimizing drug design, and identifying novel ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: The Biopharmaceutical Contract ...

Biocon share price: This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concerning its biologics business. Stocks to buy today: CLSA ...

ONGC Share Price: CLSA highlighted several key factors behind its bullish outlook for ONGC. The brokerage expects multiple volume and realization drivers for the company in 2025. A major contributor ...